Lower-Dose Oseltamivir (Tamiflu)
Filed Under (Anti Viral) by David on 04-04-2010
0
The FDA has approved a supplemental NDA (sNDA) for generic oseltamivir phosphate (Tamiflu, Roche) capsules in strengths of 30 mg and 45 mg. The lower-dose capsules provide a convenient alternative for treating and preventing influenza types A and B in patients one year of age and older. Because the capsules have a longer shelf life (five years) than the liquid suspension formulation (two years), they also offer an improved option for government stockpiling to prepare for a pandemic.
